Key Points
-
Zepp Health makes health wearables such as smartwatches, smart rings, and smart bands with biometric sensors that track the vitals of their users.
-
The stock has climbed by almost 1,100% over the past six months.
-
Even after that massive rise, Zepp may still be a good tech investment to consider.
It’s not often that a stock that skyrockets by nearly 1,100% over just six months, but that’s exactly what shares of Zepp Health (NYSE: ZEPP) have done. That meteoric rise, however, may seem a bit less impressive after one notices that the stock is still down by about 37% from where it debuted on public markets in February 2018, and off more than 60% from its peak.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Let’s take a closer look to see what has driven the market to bid this maker of health wearables higher in 2025, and what investors should do now.
Image source: Getty Images.
The market has been sold on Zepp’s success in growing sales
Zepp Health experienced numerous ups and downs in the years following its initial public offering, when it was known as Huami. Beginning in 2022, however, the stock swung sharply lower and stayed down as, after years of growth, the company’s revenue reversed course and plummeted.
ZEPP Revenue (Annual) data by YCharts.
More recently, however, Zepp delighted investors in August with second-quarter results that featured notable top-line growth, driven by strong sales of its Amazfit wearables. Zepp reported Q2 revenue of $59.4 million, a year-over-year increase of 46.2%. That exceeded the higher end of the range of $50 million to $55 million that management had forecast three months earlier.
The company also projected that robust sales growth would continue, forecasting Q3 revenue in the range of $72 million to $76 million. And it did report Q3 revenue of $75.8 million — up 78.5% year over year.
Still a good time to click the buy button on Zepp
The company is also making progress toward achieving profitability.
ZEPP Revenue (Quarterly) data by YCharts.
Granted, there’s still some risk with Zepp stock as the company continues to incur losses, but the tech stock‘s 54% pullback from an intraday high of $61.85 on Oct. 9 and the fact that it’s currently valued at only 1.2 times forward earnings suggest that now’s a good time to consider opening a position.
Should you invest $1,000 in Zepp Health right now?
Before you buy stock in Zepp Health, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Zepp Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $556,658!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,124,157!*
Now, it’s worth noting Stock Advisor’s total average return is 1,001% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of December 1, 2025
Scott Levine has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.